Chemerin as a Driver of Cardiovascular Diseases: New Perspectives and Future Directions

Area of Science:

• Immunology and Cardiovascular Science
• Endocrinology and Metabolic Research

Background:

• Cardiovascular diseases (CVDs) are a leading cause of global mortality, with obesity exacerbating their development.
• Adipokines, hormones from adipose tissue, significantly impact immune function and metabolic processes.
• Chemerin is an adipokine involved in immune cell recruitment and vascular homeostasis.

Purpose of the Study:

• To review the role of chemerin in the pathogenesis of cardiovascular diseases.
• To examine chemerin's immunomodulatory functions and impact on vascular inflammation and endothelial dysfunction.
• To explore the diagnostic and therapeutic potential of chemerin in cardiovascular health.

Main Methods:

• Literature review of recent findings on chemerin's role in cardiovascular diseases.
• Analysis of chemerin's immunomodulatory effects on immune cells and vascular function.
• Evaluation of chemerin's involvement in inflammation, insulin resistance, and blood pressure regulation.

Main Results:

• Dysregulated chemerin profiles are linked to chronic inflammation, insulin resistance, and hypertension.
• Chemerin influences the recruitment of immune cells, contributing to vascular inflammation.
• Chemerin plays a role in endothelial dysfunction, a key factor in CVD development.

Conclusions:

• Chemerin is implicated in the immunopathogenesis of various cardiovascular diseases.
• Chemerin presents potential as a diagnostic biomarker and therapeutic target for CVDs.
• Further research is warranted to fully elucidate chemerin's complex role in cardiovascular health.